2021 Hot Topics in the 340B Drug Pricing Program
Over the past year, there has been an unprecedented level of regulatory, legal, and policy developments impacting the 340B Drug Pricing Program. In this webinar, our lawyers discuss some of these developments, including 340B reimbursement under the Hospital Outpatient Prospective Payment System, contract pharmacy actions by drug manufacturers and related litigation, the status of state laws prohibiting 340B two-tier pricing models and other actions by pharmacy benefit managers, and recent federal legislative action impacting 340B stakeholders. The webinar will be moderated by Tom Mirga, Editor in Chief, 340B Report.
- Tom Mirga, Editor in Chief, 340B Report